The Pirbright Institute is a world-leading centre of excellence in the research and surveillance of virus diseases of farm animals and those that spread from animals to humans, as well as working to understand, predict, detect and respond to viral disease outbreaks. The Institute receives strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), and works to contain, control and eliminate these economically and medically important diseases through highly innovative and fundamental and applied science.
The Institute employs around 500 staff, research students and visiting scientists, and is based on one campus in Pirbright, Surrey, where £350m from UK government through BBSRC has resulted in the development of the site to incorporate a state-of-the-art high containment laboratory, the National Virology Centre: The Plowright Building. This has enabled a unique combination of fundamental and applied research into pathogenic diseases with potentially devastating impact. Additional investment of over £100m in the high containment animal facilities is nearing completion (Brooksby Building), which will enable the UK to study zoonotic diseases in livestock, a sovereign capability which was not available in the UK during the SARS-CoV-2 pandemic.
The Pirbright Institute has recently launched a new UK Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) which will bridge the gaps between research and expertise in process development and manufacturing to improve global animal health. This is a joint initiative between the BBSRC, part of UK Research and Innovation (UKRI), the Foreign, Commonwealth and Development Office (FCDO) and the Bill & Melinda Gates Foundation.
With new facilities and ground-breaking research, it's an exciting time for the Institute as it continues to deliver excellent science, underpinned by effective management of biorisk, ensuring that Pirbright remains financially viable and agile. The Institute will continue to focus on long term success by attracting optimal levels of external grant income.